Institutional quality and pandemic resilience: cross-country evidence on health and economic outcomes during COVID-19

Globalization and Health · Published 2026-07-16 · DOI 10.1186/s12992-026-01230-y

Free full text

Authors (3)

Diego A. Diaz, Cristian Larroulet, Andres Marticorena

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Diaz, D., Larroulet, C., Marticorena, A. (2026). Institutional quality and pandemic resilience: cross-country evidence on health and economic outcomes during COVID-19. Globalization and Health. https://doi.org/10.1186/s12992-026-01230-y

Related articles

• Trade, power, and public health: a political economy analysis of Thailand’s CPTPP negotiation process · Globalization and Health · 2026 · Same journal
• Improving health sector coordination for resilient healthcare systems: European lessons from the COVID-19 pandemic · Globalization and Health · 2026 · Same journal
• An account of health systems resilience to emergencies in Africa: a scoping review · Globalization and Health · 2026 · Same journal
• The policy implementation playbook: a cross-policy taxonomy of post-adoption tobacco industry tactics · Globalization and Health · 2026 · Same journal
• Strategic solidarity: solidarity and self-interest in Scandinavian contributions to global Covid-19 vaccine equity · Globalization and Health · 2026 · Same journal
• Globalization and health in an emerging new world order · Globalization and Health · 2026 · Same journal
• Insecure employment and the social determinants of suicide: a narrative synthesis review · Globalization and Health · 2026 · Same journal
• Challenges and barriers to effective COVID-19 screening at Iran’s air border crossings: a qualitative study and proposed solutions · Globalization and Health · 2026 · Same journal
• Canadian mines, global issues: examining health impacts, demanding action · Globalization and Health · 2026 · Same journal
• Building a case for accelerated clinical development of drugs and vaccines – what are the driving forces? · Globalization and Health · 2026 · Same journal